Business
Missouri judge approves Bayer's $7.25bn Roundup cancer settlement
Coverage
3 reports · 1 in Arabic, 2 in English · over 4 hours
A St. Louis state court judge has approved Bayer's $7.25 billion settlement of US lawsuits alleging its Roundup weedkiller causes cancer, covering roughly 65,000 claims.
- Judge Timothy Boyer of a Missouri state court in St. Louis approved the settlement on Friday, finding it "fair, reasonable and adequate."
- The settlement, announced in February, covers people diagnosed with lymphoma and pays individuals $10,000 to $165,000 depending on exposure, age at diagnosis and severity.
- Bayer maintains that Roundup and its active ingredient glyphosate do not cause cancer.
- Chief executive Bill Anderson said the approval was "a decisive milestone" in the company's strategy to mitigate Roundup litigation risk.
- Bayer will pay the settlement through annual instalments into a fund over as long as 21 years, rather than as a single lump sum.
- The deal also covers Roundup users who fall ill in future, beyond those already diagnosed with non-Hodgkin lymphoma.
- Bayer has already paid roughly $10 billion in earlier US Roundup litigation, according to the report.

